MEDICINE DETAILS
Tremfya
Active ingredient: Guselkumab
Neutral reference profile for an independent medicine-access consultancy enquiry about Tremfya (Guselkumab). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Tremfya used for?
Tremfya (guselkumab) is an interleukin 23 antagonist indicated for the treatment of adult patients with:
- Moderate-to-severe plaque psoriasis who are candidates for systemic therapy or light therapy
- Active psoriatic arthritis (PsA)
It is available as a single-dose syringe containing 100 mg guselkumab.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Tremfya identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
45 mg/0.45 ml solution for injection · 1 pen Catalogue organisation: JANSSEN-CILAG GmbH
-
100 mg solution for injection · 1 pen Catalogue organisation: kohlpharma GmbH
-
100 mg solution for injection · 1 pre-filled syringe Catalogue organisation: kohlpharma GmbH
-
100 mg solution for injection · 2 pens Catalogue organisation: Abacus Medicine A/S
-
100 mg solution for injection · 2 pre-filled syringes Catalogue organisation: Abacus Medicine A/S
-
200 mg concentrate for solution for infusion · 1 vial Catalogue organisation: JANSSEN-CILAG GmbH
-
200 mg solution for injection · 1 pen Catalogue organisation: JANSSEN-CILAG GmbH
-
200 mg solution for injection · 1 pre-filled syringe Catalogue organisation: JANSSEN-CILAG GmbH
-
200 mg solution for injection · 2 pens Catalogue organisation: JANSSEN-CILAG GmbH
-
200 mg solution for injection · 2 pre-filled syringes Catalogue organisation: JANSSEN-CILAG GmbH
OFFICIAL SOURCES
Check the Tremfya record at an official source.
Search for “Tremfya” or “Guselkumab”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Tremfya.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Tremfya
01What is Tremfya?＋
This directory record associates the brand name Tremfya with the active ingredient Guselkumab. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Tremfya strengths and packs are recorded?＋
The catalogue currently shows: 45 mg/0.45 ml solution for injection · 1 pen; 100 mg solution for injection · 1 pen; 100 mg solution for injection · 1 pre-filled syringe; 100 mg solution for injection · 2 pens. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Tremfya?＋
Catalogue records currently name: JANSSEN-CILAG GmbH, kohlpharma GmbH, Abacus Medicine A/S. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Tremfya?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Tremfya, payment request, stock guarantee or binding offer.
06Can I buy Tremfya from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.